TO 
070305616194555805 P.02 
DEC-23-1993 10: 17 FROH U OF C / HEnONC 
FF Principal Investtgaioc/Pfogfam Direclof (Last, first, middle): 
Voqelzanq NJ , Lanzotti VJ, Muntean B, Blough RR: Bisantrene in advanced hormone-resistant 
carcinoma of the prostate. An American Cancer Society, Illinois Cancer Council Phase 
II Study. Invest New Drugs, 8:313-315, 1990. 
Voqelzanq NJ : Cisplatin and etoposide for metastatic testis cancer in a renal transplant 
recipient. J Urol, 143:1236-36 1990. 
Voqelzanq NJ . Goutsou M, Corson JM, Suzuki Y, Graziano S, Aisner J, Cooper MR, Mason- 
Coughlin KM, Green MR: Carboplatin in malignant mesothelioma. A phase II study of the 
Cancer and Leukemia Group B. Cancer Chemo Pharm, 27:239-242, 1990. 
Chodak GW, Voqelzanq NJ , Caplan RJ, Soloway MS, Smith JA: Independent prognostic factors 
In patients with metastatic (stage D^) Prostate Cancer. J Amer Med Assoc, 265:618-621 
Soloway MS, Chodak GW, Voqelzanq NJ . Block NL, Schellhammer PS, Smith JA, Scott M, 
Kennealey GT, Gau TC: Zoladex vs. orchiectomy in treatment of advanced prostate 
cancer: A randomized trial. Urology, 37:46-51, 1991. 
Farah R, Chodak GW, Voqelzanq NJ . Awan AM, Quiet CA, Moormeier JA, Schoenberg HW, 
Weichselbaum RR: Curative radiotherapy following chemotherapy for invasive bladder 
carcinoma: A preliminary report. Int J Radia Oncol Biol Phys, 20:413-417, 1991. 
Bennett CL, Greenfield S, Aronow HU, Ganz Py Voqel'zanq NJ , Elashoff RM: Patterns of care 
related to age of men with prostate cancer. Cancer, 67:2633-2641, 1991. 
Silver RI, Straus FH, Voqelzanq NJ ,- Kellman HL, Chodak GW: Response to orchiectomy 
following Zoladex therapy for met^tatic prostate carcinoma. Urology, 37:17-21, 1991. 
Vokes EE, Raschko JW, Voqelzanq NJ . Warfield EE, Ratain MJ, Doroshow JH, Schilsky RL: 
- Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin. A phase I 
study' of the Cancer and Leukemia Group B. Cancer Chemo Pharm, 28:69-73, 1991. / 
Sesterhenn lA, Weis RB, Mostofi FK, Stablein DM, Rowland RG, Falkson G, Rivkind SE, 
Voqelzanq NJ : Prognosis and other clinical correlates of pathologic review in stages 
- I. and II testicular carcinoma. A report from the Testicular Cancer Intergroup study, 
^ner J Clin Oncol, 10:69-78, 1992. 
Guinan PO, Voqelzanq NJ . Randazzo R, fremgen AM, Chmiel JS, Scheinfeld J, Sener SF: Renal 
pelvic transitional cell carcinoma: The role of the kidney in tumor-node-metastasis 
. staging. Cancer, 69:1773-1775, 1992. 
Nakagawa. Y, Sirivongs D, Novy MB, Netzer MF, Michaels E, Voqelzanq NJ ,. Coe. FL: 
Nephrocalcin: Biosynthesis by human renal carcinoma cells in vitro and in vivo. 
Cancer Res, 52:1573-1579, 1992. 
GuiTian PD, Voqelzanq NJ . Randazzo R, Chmiel JS, Fremgen AM, Scheinfeld J, Sener SF: Renal 
pelvic cancer: A review of 611 patients treated in Illinois 1975-1985. Urology, 
40:393-399, 1992. • ' 
VoqeTzanq NJ , Priest ER, Borden L: Spontaneous regression of histologically proven 
pulmonary metastases from renal cell carcinoma: A case with five year follow-up. J 
... .Urol, 148:1247-1248, 1992. u --.. . 
Stadle.r-.;,WM, Voqelzanq NJ , Vokes EE, Charette J, Whitman G: Continuous-infusion 
fluo rpdeoxy uridine with leucovorin and high-dose interferon: A phase II study in 
•metastatic renal-cell cancer. Cancer Chemo Pharm, 31:213-216, 1992. 
^ Voqelzanq NJ . Moormeier JA, Awan AM, Weichselbaum RR, Farah R, Straus FH, Schoenberg HW, 
Chodak GW: M-VAC followed by radiotherapy or surgery for muscle-invading bladder 
cancer: The University of Chicago experience. J Urol, 149:753-757, 1993. n.i 
Voqelzanq NJ . Lipton A, Figlin R: Subcutaneous interleukin-2 plus interferon alpha-2A in 
metastatic renal cancer: an outpatient roulticenter trial. Amer. J Clin Oncol, 
. •11(31:1809-16, 1993. ; 
■■ We ii-RB,' Voqelzanq NJ . Peterson BA, Panasci LC, Gavigan M, Sartell K, Frei E, McIntyre OR: 
1 ^.. Alsuccessfu system of scientific data audits for clinical trials: A report; from the 
v - : Ceihcer and Leukemia Group B. J Amer Med Assoc, 270:459-464, 1993. 
Voqelzanq NJ . Fremgen AM, Guinan PO, Chmiel JS, Sylvester JL, Sener SF: Primary renal 
'•• sarcoma in adults: A natural history and management study by the American Cancer 
. . So'clety, Illinois Division. Cancer, 71:804-810, 1993. 
i 
Recombinant DNA Research, Volume 19 
1231] 
